Publication | Closed Access
Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
52
Citations
22
References
2017
Year
The combined use of two non-invasive serum biomarkers (APRI and FIB-4) could stratify HCC risk for chronic HBV-infected patients with LLV.
| Year | Citations | |
|---|---|---|
Page 1
Page 1